Gene-level pharmacogenetic analysis on survival outcomes using gene-trait similarity regression

DOI10.1214/14-AOAS735MaRDI QIDQ400685zbMATH OpenOpenAlexWikidataFDO

Authors Jung-Ying Tzeng, Wenbin Lu, Fang-Chi Hsu

Publication date 22 August 2014

Published in The Annals of Applied Statistics (Search for Journal in Brave)

Full work available at URL https://arxiv.org/abs/1408.0083, https://projecteuclid.org/euclid.aoas/1404229532

zbMATH Keywords

proportional hazards modelproportional odds modelsurvival dataassociation studygene/pathwaypharmacogeneticssimilarity regression

Mathematics Subject Classification ID

Estimation in survival analysis and censored data (62N02) Applications of statistics to biology and medical sciences; meta analysis (62P10)

Abstract: Gene/pathway-based methods are drawing significant attention due to their usefulness in detecting rare and common variants that affect disease susceptibility. The biological mechanism of drug responses indicates that a gene-based analysis has even greater potential in pharmacogenetics. Motivated by a study from the Vitamin Intervention for Stroke Prevention (VISP) trial, we develop a gene-trait similarity regression for survival analysis to assess the effect of a gene or pathway on time-to-event outcomes. The similarity regression has a general framework that covers a range of survival models, such as the proportional hazards model and the proportional odds model. The inference procedure developed under the proportional hazards model is robust against model misspecification. We derive the equivalence between the similarity survival regression and a random effects model, which further unifies the current variance component-based methods. We demonstrate the effectiveness of the proposed method through simulation studies. In addition, we apply the method to the VISP trial data to identify the genes that exhibit an association with the risk of a recurrent stroke. The TCN2 gene was found to be associated with the recurrent stroke risk in the low-dose arm. This gene may impact recurrent stroke risk in response to cofactor therapy.

Recommendations

• A penalized likelihood approach for investigating gene-drug interactions in pharmacogenetic studies
• Gene-based association analysis for bivariate time-to-event data through functional regression with copula models
• Gene-Trait Similarity Regression for Multimarker-Based Association Analysis
• Survival analysis: parametrics to semiparametrics to pharmacogenomics
• Two-Level Bayesian Interaction Analysis for Survival Data Incorporating Pathway Information

Cites work

• scientific article; zbMATH DE number 3385132 (Why is no real title available?)
• Analysis of transformation models with censored data
• Computing the distribution of quadratic forms: further comparisons between the Liu-Tang-Zhang approximation and exact methods
• Efficient estimation of semiparametric transformation models for counting processes
• Gene-Trait Similarity Regression for Multimarker-Based Association Analysis
• Kernel Machine Approach to Testing the Significance of Multiple Genetic Markers for Risk Prediction
• Note on an Approximation to the Distribution of Non-Central χ 2
• Semiparametric analysis of transformation models with censored data
• Tests for high-dimensional regression coefficients with factorial designs
• The Robust Inference for the Cox Proportional Hazards Model

Cited in

(1)

• A penalized likelihood approach for investigating gene-drug interactions in pharmacogenetic studies

This page was built for publication: Gene-level pharmacogenetic analysis on survival outcomes using gene-trait similarity regression

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q400685)